These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8607524)

  • 21. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J; Emparan C; Hernandez CA; Sulkowski U; Dietl KH; Menzel J; Wolters H; Glodny B; Senninger N
    Anticancer Res; 2000; 20(6D):4941-7. PubMed ID: 11326643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brush cytology and the diagnosis of pancreaticobiliary malignancy during ERCP.
    Lee JG
    Gastrointest Endosc; 2006 Jan; 63(1):78-80. PubMed ID: 16377320
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study.
    Fogel EL; deBellis M; McHenry L; Watkins JL; Chappo J; Cramer H; Schmidt S; Lazzell-Pannell L; Sherman S; Lehman GA
    Gastrointest Endosc; 2006 Jan; 63(1):71-7. PubMed ID: 16377319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
    Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Respiratory insufficiency resulting in death in a patient with abdominal pain, generalized adenopathies and enlarged pancreas: case record].
    Jiménez Sáenz M; Caunedo Alvarez A; García Escudero A; Linares Cuartero A; Herrerías Gutiérrez JM; Herrerías Esteban JM; Galera Davidson H
    Rev Esp Enferm Dig; 1998 Dec; 90(12):877-81. PubMed ID: 9973850
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum evaluation of P53 protein in patients with gynaecological cancer.
    Barbati A; Mariani L; Porpora MG; Anceschi M; Collini P; Lauro V; Cosmi EV
    Anticancer Res; 2000; 20(2A):1033-5. PubMed ID: 10810393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of serum anti-p53 antibodies in patients with various types of cancer].
    Sakai H
    Rinsho Byori; 2002 Jan; 50(1):90-2. PubMed ID: 11871143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV; Edwards R; Ho S; Lau WY; Glazer G
    Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of serum p53 antibodies in mucosal esophageal cancer and negative conversion after treatment.
    Shimada H; Arima M; Nakajima K; Koide Y; Okazumi S; Matsubara H; Miyazawa Y; Takeda A; Hayashi H; Yoshida T; Ochiai T; Isono K
    Am J Gastroenterol; 1998 Aug; 93(8):1388-9. PubMed ID: 9707082
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 33. Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma.
    Brockmann JG; Hernandez CA; Emparan C; Wolters H; Haier J; Dietl KH; Senninger NJ
    Anticancer Res; 2003; 23(2A):819-25. PubMed ID: 12820306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms.
    Goldstein NS; Bassi D; Uzieblo A
    Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
    Saffroy R; Lelong JC; Azoulay D; Salvucci M; Reynes M; Bismuth H; Debuire B; Lemoine A
    Br J Cancer; 1999 Feb; 79(3-4):604-10. PubMed ID: 10027337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
    Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
    Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The case for parallel classification of biliary tract and pancreatic neoplasms.
    Longnecker DS; Terhune PG
    Mod Pathol; 1996 Aug; 9(8):828-37. PubMed ID: 8871924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of pre-malignant disease of the pancreatico-biliary system.
    Friess H; Holzinger F; Liao Q; Büchler MW
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):285-300. PubMed ID: 11355916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
    Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.